Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.709 USD | +7.03% | -15.71% | +26.61% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | Tiziana Life Sciences Says US FDA Allows Enrollment of 20 More Patients in Foralumab MS Expanded Access Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+26.61% | 66.44M | |
+26.17% | 42.68B | |
-4.11% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.64% | 24.94B | |
-21.54% | 18.96B | |
+27.59% | 12.3B | |
-2.99% | 11.95B | |
-1.76% | 11.55B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Initiates Phase 2a Trial of Intranasal Foralumab for Non-Active Secondary Progressive Multiple Sclerosis